The orphan drug market has been a standout performer over the past decade, doubling its market share and outperforming the broader pharmaceutical sector. But is the sparkle starting to fade?
Our latest infographic overviews the trends that suggest a possible slowdown. Despite these signs, the sector is still buoyed by a few standout drugs and continuous innovations. With major regulatory changes afoot, what could this mean for the future?
Download our infographic for a snapshot of the critical shifts shaping the orphan drug market.
